CLARA AMPADU: Open Payments
NPI 1578096806 · SWANSEA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 75 payments from 26 companies in 2025. Trend: 2023 $1,508 · 2024 $1,368 · 2025 $1,445
Food & beverage: $1,334Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 23 | $317 |
| Lundbeck LLC | 5 | $110 |
| Novo Nordisk Inc | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| SANOFI-AVENTIS U.S. LLC | 3 | $67 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Amphastar Pharmaceuticals, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $54 |
Products named: REXULTI, AUSTEDO XR, TZIELD, SPRAVATO, COBENFY, Kerendia, Ohtuvayre, Auvelity.
Industry payments across IL — which companies pay providers there.
